On Jan. 14, 2020, Evotec announced that the wholly-owned Seattle based company Just – Evotec Biologics had initiated the construction of a late-stage clinical and commercial manufacturing facility for biologics in Redmond, Washington.

The innovative cGMP biomanufacturing facility employed Just – Evotec Biologics’ J.POD technology using small, intensified bioprocessing operations housed inside autonomous cleanrooms.